Clinical applications for tissue engineered vascular grafts (TEVG) include arterial bypass and hemodialysis access.
•
TEVGs must be non-antigenic, durable, cost-effective, and remain patent to be feasible.
•
Advances in cell culture, scaffolds, biomaterials, and manufacturing enhance TEVG feasibility.
•
Newer technologies such as electrospinning and 3D-printing are available to manufacture TEVG.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.